Scar Treatment Market Size, Share & Industry Analysis By Product (Topical, Laser, Injectable, Others), By Type (Hypertrophic and Keloids, Contractures, Stretch Marks, Others), By End User (Hospitals, Specialty Clinics, Others) And Regional Forecast 2023-2030

Scars are caused due to any burn injury or other trauma condition, including surgeries. The appearance and treatment of scars after an injury depends upon various factors, however, these treatments reduce the scars but do not completely remove them. The scar revision procedure is used to minimize the scars in a way that they appear more consistent with the surrounding tone and texture of the skin. Scars are the visible signs that prevail even after a wound heals. The results of injuries or surgeries are unavoidable, and the development of scars is predictable.

The growing concern among people regarding their aesthetic appearance is one of the major factors driving the demand for scar treatment products. Road accidents are also an important factor that contributes to market growth as they can cause scars and other marks. Burn incidents have increased significantly grown over the years and is one of the most important reasons for the growth of scar treatment market.

The global scar treatment market is technology-driven. The introduction of new technologies in the market increases the demand for these systems due to improved efficiency and outcomes. However, the high cost of these new devices leads to an affordability issue, which restraints the growth of the global scar treatment market, especially in developing countries.

Key Market Driver -

Increasing burn incidents is expected to boost the growth of the market.

Key Market Restraint -

High cost of treatment and complications are expected to hinder the market growth

Market Segmentation:

Globally, the scar treatment market can be segmented on the basis of product, type, end user and region. Based on product, the market can be segmented into topical, laser, injectables and others. Based on type, the market can be segmented into hypertrophic and keloid, contractures, stretch marks, and others. Based on end user, the market can be segmented into hospitals, specialty clinics, and others. Geographically, the global market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.

Key Players Covered:

The major companies in the global scar Treatment market report include Smith + Nephew, Merz Pharma, Lumeins., Sientra, Inc., Sonoma Pharmaceuticals, Inc., Mölnlycke Health Care AB., Cynosure, CCA Industries, Inc. Newmedical Technology, Inc., Suneva Medical, and other prominent players.

Key Insights

• New Product Launches


• Overview of R&D Advances in Scar Treatment


• Impact of COVID-19 on the Global Scar Treatment Market


• Key Industry Development - Mergers and Acquisitions

Regional Analysis:

North America dominates the scar treatment market due to the high number of road accidents, increasing disposable incomes coupled with increasing spending on personal care products will boost demand. The prevalence of skin disorders like acne will favour the regional industry's growth.

The scar treatment market of Latin American regions is expected to grow at a high rate owing to an increase in desire among the population to look beautiful and high per capita expenditure on cosmetic procedures. An increase in medical tourism for undergoing various cosmetic procedures would further aid industry expansion in the scar treatment market.

Key countries in the Asia Pacific region exhibit profitable growth due to the presence of a large population base with unmet needs. Growing awareness regarding scar treatment will also boost market growth in the region. Latin America and the Middle East and Africa region are supposed to witness growth in the forecast period due to the increased presence of key market players.

To gain extensive insights into the market, Request for Customization

Segmentation

Scar Treatment Industry Developments

• In August 2019, researchers at the Naval Medical University, China, reported that minced split-thickness skin grafts with Pelnac acts as an overlay which can be effective in reconstruction of full-thickness skin defects.


• In April 2017, Sonoma Pharmaceuticals received regulatory approvals for a new pediacyn for atopic dermatitis and epicyn for scar management in United Arab Emirates.